stockrowBio-Rad Laboratories, Inc. (BIO.B) vs Bruker Corporation (BRKR)
- Bio-Rad Laboratories, Inc. BIO.B 379.50 +4.22%
- Bruker Corporation BRKR 61.31 +5.60%
Bio-Rad Laboratories, Inc. and Bruker Corporation are both Medical Devices companies. Bio-Rad Laboratories, Inc. is the larger, with a market value of $10.3B against $8.9B — 1.2× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Bio-Rad Laboratories, Inc. trades at 9.9×. Bruker Corporation grew revenue faster over the last twelve months: 2.16% against 1.38%. Bio-Rad Laboratories, Inc. has the higher net margin (39.5% vs −4.76%) and the higher return on invested capital (−0.44% vs −1.12%). Across the 20 metrics below, Bio-Rad Laboratories, Inc. leads on 14 and Bruker Corporation on 6.
Valuation
Profitability
| Metric | BIO.B | BRKR | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.26% | 47.66% | 57.76% |
| Operating margin | (2.39%) | (1.99%) | (15.07%) |
| Net margin | 39.45% | (4.76%) | (14.45%) |
| Free cash flow margin | 18.05% | 6.97% | (3.88%) |
| Return on equity | 14.27% | (7.04%) | (10.35%) |
| Return on assets | 9.99% | (2.73%) | (17.26%) |
| Return on invested capital | (0.44%) | (1.12%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack